The AI scribe company said information from the New England Journal of Medicine and the JAMA Network will allow providers to more easily access the latest medical research.

Abridge launched into the healthcare market eight years ago as an artificial intelligence scribe, but the company has been ...

Peer-reviewed medical research, published by the New England Journal of Medicine and the JAMA Network, will be accessible ...